Brief: IRLAB Therapeutics Gets Approvals For Phase Ib Study Of IRL757

IRLAB Therapeutics AB

23/12/2025 06:03

Dec 23 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

RECEIVES APPROVALS FOR PHASE IB STUDY OF IRL757

Source text: ID:nMFN4YX5bF

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))